Skip Navigation


Journal of the National Cancer Institute Advance Access originally published online on April 28, 2009
JNCI Journal of the National Cancer Institute 2009 101(9):630-643; doi:10.1093/jnci/djp068
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
101/9/630    most recent
djp068v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Ballard-Barbash, R.
Right arrow Articles by Schatzkin, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ballard-Barbash, R.
Right arrow Articles by Schatzkin, A.
Related Collections
Right arrowRelated Article in JNCI
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published by Oxford University Press 2009.

COMMENTARY

Physical Activity, Weight Control, and Breast Cancer Risk and Survival: Clinical Trial Rationale and Design Considerations

Rachel Ballard-Barbash, Sally Hunsberger, Marianne H. Alciati, Steven N. Blair, Pamela J. Goodwin, Anne McTiernan, Rena Wing, Arthur Schatzkin

Affiliations of authors: Applied Research Program, Division of Cancer Control and Population Sciences (RB-B), Biometric Research Branch, Division of Cancer Treatment (SH), and Nutrition Epidemiology Branch, Division of Cancer Epidemiology and Genetics (AS), National Cancer Institute, National Institutes of Health, Bethesda, MD; Scientific Operations, Susan G. Komen for the Cure, Dallas, TX (MHA); Department of Exercise Sciences, University of South Carolina, Columbia, SC (SNB); Department of Medicine, University of Toronto, Mount Sinai Hospital, Toronto, CA (PJG); Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, WA (AMT); Centers for Behavioral and Preventive Medicine, The Miriam Hospital and Brown University, Providence, RI (RW)

Correspondence to: Rachel Ballard-Barbash, PhD, Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, EPN 4005, Executive Blvd, Bethesda, MD 20892-7344 (e-mail: barbashr{at}mail.nih.gov).

Substantial observational epidemiological evidence exists that physical activity and weight control are associated with decreased risk of postmenopausal breast cancer. Uncertainty remains regarding several aspects of these associations, including the effect of possible confounding factors on these associations. We present the rationale and design for two randomized controlled trials that can help resolve this uncertainty. In a 5-year prevention trial conducted among women at high risk of breast cancer, the primary endpoint would be breast cancer incidence. For a comparable survivorship trial, the primary endpoint would be the disease-free interval and secondary endpoints would be breast cancer recurrence–free interval, second primary breast cancer, and total invasive plus in situ breast cancer. A set of inclusion and exclusion criteria is proposed for both trials. Intervention goals are the same for both trials. Goals for the weight control intervention would be, for women whose body mass index (BMI) is greater than 25 kg/m2, to lose 10% of body weight and, for women whose BMI is less than or equal to 25 kg/m2, to avoid weight gain. The goal for the physical activity intervention would be to achieve and maintain regular participation in a moderate-intensity physical activity program for a total of 150–225 minutes over at least 5 days per week. Sample size calculations are based on alternative assumptions about hazard ratio, adherence, follow-up duration, and power and are presented for the primary prevention and survivorship trials. Although both studies could enhance our understanding of breast cancer etiology and benefit public health, practical considerations, including smaller sample size, ease of recruitment, and reduced likelihood of early termination, favor the survivorship trial at this time.


Manuscript received September 2, 2008; revised January 29, 2009; accepted February 27, 2009.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Article in JNCI

IN THIS ISSUE
J Natl Cancer Inst 2009 101: 613. [Extract] [Full Text] [PDF]





Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.